KARIN L. WALKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2021-04-29 Karin L. Walker ... Class 1 Director ... Ms. Walker has served as a director ... The Audit Committee during such period had four members: Dr. Christopher Henney (Chairman), Gregory T. Hradsky, Dr. Samuel L. Barker, and Karin L. Walker. ... Total ($) 21,813
2022-04-26 Karin L. Walker ... Class 1 Director Nominee ... The Audit Committee during such period had four members: Karin L. Walker (Chair), Dr. Christopher Henney, Dr. Samuel L. Barker and Gregory T. Hradsky. ... Karin L. Walker ... Total ($) 132,346
2023-04-28 "Karin L. Walker 60 Class 1 Director" and "Audit Committee... Karin L. Walker (Chair)"; "Nominating and Corporate Governance Committee consists of ... Karin L. Walker"; "Total $112,000"
2024-05-08 Karin L. Walker ... Class 1 Director ... Audit Committee during such period had four members: Karin L. Walker (Chair), Dr. Christopher Henney, Dr. Samuel L. Barker and Dr. Robert J. Spiegel ... Nominating and Corporate Governance Committee consists of Dr. Christopher S. Henney (Chairman), Karin L. Walker and Dr. Robert J. Spiegel

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06